Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis

Autor: Mulcahy B, Waldron-Lynch F, Mf, Mcdermott, Adams C, Ci, Amos, Dk, Zhu, Rh, Ward, Do, Clegg, Fergus Shanahan, Mg, Molloy, O'Gara F

Publikováno v: Europe PubMed Central

The major histocompatibility complex class III tumor necrosis factor-lymphotoxin (TNF-LT) region (6p21.3) was investigated as a possible susceptibility locus for rheumatoid arthritis (RA). Inheritance of five TNF microsatellite markers was determined

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b93a7e26f90663458aa04e412662bf19
https://pubmed.ncbi.nlm.nih.gov/8751869

[Untitled]

Autor: MF McDermott, M Rynne, C Maclean, Paul Emery

Publikováno v: Arthritis Research & Therapy. 7:P96

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::894c1c6cc9fa3fd1b2b213bcde22a561
https://doi.org/10.1186/ar1617

Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor

Autor: Sarah Churchman, Geiler J, Parmar R, Ea, Horner, Ld, Church, Emery P, Mh, Buch, Mf, Mcdermott, Ponchel F

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2de06736c7b5a576ade580941ba354e7
http://europepmc.org/abstract/med/22704737

Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult-onset Still's disease.

Autor: Topping J; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Chang L; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Nadat F; Department of Clinical Immunology and Allergy, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK., Poulter JA; Leeds Institute of Medical Research, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK., Ibbotson A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Lara-Reyna S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Watson CM; Leeds Institute of Medical Research, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK.; North East and Yorkshire Genomic Laboratory Hub, Central Lab, St. James's University Hospital, Leeds, UK., Carter C; Department of Clinical Immunology and Allergy, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK., Pournara LP; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Zernicke J; Charité Universitätsmedizin Berlin, Rheumatology and Clinical Immunology, Germany., Ross RL; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.; National Institute for Health Research - Leeds Biomedical Centre, Chapel Allerton Hospital, Leeds, LS7 4SA, UK., Cargo C; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK., Lyons PA; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, CB2 0AW, UK., Smith KGC; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.; The Walter and Eliza Hall Institute of Medical Research (WEHI) , 1G Royal Parade, Parkville, VIC, 3050, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3052, Australia., Del Galdo F; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.; National Institute for Health Research - Leeds Biomedical Centre, Chapel Allerton Hospital, Leeds, LS7 4SA, UK., Rech J; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University (FAU)Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum Immuntherapie, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.; Center for Rare Diseases Erlangen (ZSEER), Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany., Fautrel B; Sorbonne University - Assistance Publique Hopitaux de Paris, Pitié-Salpêtrière Hospital, Rheumatology Dept, INSERM UMR, 1136, Paris, France., Feist E; Experimental Rheumatology OvGU Magdeburg and Helios Clinic, Department of Rheumatology and Clinical Immunology, Gommern, Germany., McDermott MF; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK., Savic S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK.; Department of Clinical Immunology and Allergy, St James's University Hospital, Beckett St, Leeds, LS9 7TF, UK.; National Institute for Health Research - Leeds Biomedical Centre, Chapel Allerton Hospital, Leeds, LS7 4SA, UK.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

Inflammatory profile of lower risk myelodysplastic syndromes.

Autor: Topping J; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Taylor A; Epidemiology and Cancer Statistics Group, University of York, York, UK., Nadat F; Department of Clinical Immunology and Allergy, St James's University Hospital, Leeds, UK., Crouch S; Epidemiology and Cancer Statistics Group, University of York, York, UK., Ibbotson A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Čermák J; Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Praha, Czech Republic., Symeonidis A; Division of Hematology, Department of Internal Medicine, University of Patras Medical School, Patras, Greece., Tatic A; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Langemeijer S; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Hellström-Lindberg E; Division of Hematology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., Culligan D; Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK., Garelius HG; Department of Specialist Medicine, Sahlgrenska University Hospital, Göteborg, Sweden., Ashcroft J; Department of Hematology, Mid Yorkshire Hospitals, Wakefield, UK., Nga E; Department of Haematology, Royal Blackburn Teaching Hospital, Blackburn, Lancashire, UK., Parker J; Northampton General Hospital, Northampton, UK., Kolade S; Department of Haematology, Blackpool Victoria Hospital, Blackpool, Lancashire, UK., McDermott MF; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., De Witte T; Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bowen D; Epidemiology and Cancer Statistics Group, University of York, York, UK., Smith A; Epidemiology and Cancer Statistics Group, University of York, York, UK., Cargo C; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK., Savic S; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.; National Institute for Health Research-Leeds Biomedical Research Centre, Leeds, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1044-1054. Date of Electronic Publication: 2024 May 21.